Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Keratosis, Actinic × Niacin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Depression 2 Anxiety Disorders 2 Skin Neoplasms 1 Polycystic Ovary Syndrome 1 Keratosis, Actinic 1

Interventions

3-ingenyl angelate 39 Imiquimod 21 Aminolevulinic Acid 19 Photochemotherapy 15 Fluorouracil 11 Diclofenac 11 Gels 10 methyl 5-aminolevulinate 9 Cryotherapy 6 Solutions 5 tirbanibulin 4 Radiotherapy 4 Prilocaine 4 Lidocaine 4 LEO 43204 4 Petrolatum 3 Ointments 3 Cryosurgery 3 BF-200 ALA 3 calcipotriene 2 SR-T100 2 Niacinamide 2 1-phenyl-3,3-dimethyltriazene 2 tazarotene 1 potassium dobesilate 1 perillyl alcohol 1 endonuclease V, phage T4 1 dexpanthenol 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 beta-solamarine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04843553 2021-04-22

NICE

Rhode Island Hospital

Phase EARLY_PHASE1 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡